2490542-33-9

2490542-33-9 structure
2490542-33-9 structure
  • Name: Bcl-2-IN-9
  • Chemical Name: Bcl-2-IN-9
  • CAS Number: 2490542-33-9
  • Molecular Formula: C27H31N7O3S
  • Molecular Weight: 533.65
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2022-08-16 18:59:22
  • Modify Date: 2024-01-11 19:09:57
  • Bcl-2-IN-9 is a novel proapoptotic Bcl-2 inhibitor with IC50 value of 2.9 μM and low cytotoxic. Bcl-2-IN-9 mediates apoptosis by down-regulating expression of Bcl-2 in cancer cells and has a high selectivity against leukemia cells[1].

Name Bcl-2-IN-9
Description Bcl-2-IN-9 is a novel proapoptotic Bcl-2 inhibitor with IC50 value of 2.9 μM and low cytotoxic. Bcl-2-IN-9 mediates apoptosis by down-regulating expression of Bcl-2 in cancer cells and has a high selectivity against leukemia cells[1].
Related Catalog
Target

Bcl-2:2.9 μM (IC50, [1])

In Vitro Bcl-2-IN-9 (compound 6e) (10 μM, 48 hours) inhibits HL-60 cells in vitro[1]. Bcl-2-IN-9 (compound 6e) (10 μM, 48 hours) shows low cytotoxic effects against WI-38 cells with cell viability of 91%[1]. Bcl-2-IN-9 (compound 6e) (10 μM, 48 hours) displays a high selectivity against leukemia cells[1]. Bcl-2-IN-9 (compound 6e) (10 μM) mediates apoptotic by down-regulating expression of Bcl-2 and causing chromatin compaction and nuclear fragmentation[1]. Cell Viability Assay[1] Cell Line: HL-60 cells Concentration: 1, 10, 20, 40 μM Incubation Time: 48 hours Result: Surpressed cell growth and viability to 28.9%. Cell Cytotoxicity Assay[1] Cell Line: WT-38 cells Concentration: 10 μM Incubation Time: 48 hours Result: Low cytotoxic effects. Apoptosis Analysis[1] Cell Line: HL-60 cells Concentration: 1, 10, 20, 40 μM Incubation Time: 48 hours Result: Caused chromatin compaction and nuclear fragmentation.
References

[1]. Yukari Ono, et al. Design and synthesis of quinoxaline-1,3,4-oxadiazole hybrid derivatives as potent inhibitors of the anti-apoptotic Bcl-2 protein. Bioorg Chem. 2020 Aug; 104: 104245.

Molecular Formula C27H31N7O3S
Molecular Weight 533.65